Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Mirum Pharmaceuticals, Inc. (MIRM) had Cash Flow from Investing Activities of $-107.20M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$186.37M |
|
$-163.41M |
|
$47.04M |
|
$139.34M |
|
$295.53M |
|
$-109.15M |
|
$-53.27M |
|
$-162.42M |
|
$-162.42M |
|
$-163.41M |
|
$-163.41M |
|
$-163.41M |
|
$-163.41M |
|
$-109.15M |
|
$-97.21M |
|
40.88M |
|
40.88M |
|
$-4.00 |
|
$-4.00 |
|
| Balance Sheet Financials | |
$387.54M |
|
$0.71M |
|
$259.08M |
|
$646.62M |
|
$87.06M |
|
$306.42M |
|
$310.89M |
|
$397.95M |
|
$248.67M |
|
$-4.25M |
|
$248.67M |
|
46.72M |
|
| Cash Flow Statement Financials | |
$-70.94M |
|
|
Cash Flow from Investing Activities |
$-107.20M |
$336.60M |
|
$128.00M |
|
$286.33M |
|
$158.32M |
|
$35.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.45 |
|
-- |
|
-- |
|
0.55 |
|
1.23 |
|
74.76% |
|
-58.57% |
|
-58.57% |
|
-52.16% |
|
-87.15% |
|
-87.68% |
|
$-71.05M |
|
-- |
|
-- |
|
-- |
|
0.29 |
|
2.11 |
|
2.74 |
|
133.11 |
|
-65.72% |
|
3840.52% |
|
-25.27% |
|
-29.44% |
|
$5.32 |
|
$-1.74 |
|
$-1.74 |
|